Psychiatry

Back to articles

Psychotropic Medication in Young Children: Use Exceeds Available Data

KEY POINT

Given the paucity of available research data or even empiric evidence, an increasing amount of off-label use of psychotropic medications in young children has attracted critical attention in both the professional and lay media. Especially for attention-deficit hyperactivity disorder (ADHD), improved assessment, treatment, and follow-up means are needed—as well as more data from sound clinical studies.

SOURCES

Zito JM et al. Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000;283:1025–30.Coyle JT. Psychotropic drug use in very young children. JAMA. 2000;283:1059–60.

National Institutes of Health Consensus Development Conference statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). J Am Acad Child Adolesc Psychiatry. 2000;39:182–93.

Jensen PS. Commentary: the NIH ADHD statement: win, lose, or draw? J Am Acad Child Adolesc Psychiatry. 2000;39:194–7.

Klassen A et al. Attention-deficit hyperactivity disorder in children and youth: a quantitative systemic review of the efficacy of different management strategies. Can J Psychiatry. 1999;44:1007–16.